Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.05p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.50
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 690,953
  • Market Cap: £16.03m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 5.50 (49.43) (21.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 13.09 (32.38) (5.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 26.62 (16.24) (2.49)p n/a n/a n/a n/a 0.0%
31-Dec-25 56.56 (5.35) (1.07)p n/a n/a n/a n/a 0.0%
31-Dec-26 50.88 (3.31) (0.63)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 2.05p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.50
52 Week Low 1.23
Volume 690,953
Shares Issued 782.06m
Market Cap £16.03m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.53% below the market average15.53% below the market average15.53% below the market average15.53% below the market average15.53% below the market average
84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average
Price Trend
93.96% below the market average93.96% below the market average93.96% below the market average93.96% below the market average93.96% below the market average
88.68% below the sector average88.68% below the sector average88.68% below the sector average88.68% below the sector average88.68% below the sector average
Income Not Available
Growth
61.14% above the market average61.14% above the market average61.14% above the market average61.14% above the market average61.14% above the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
16:18 50,000 @ 2.01p
15:31 18,000 @ 2.10p
14:55 1,000 @ 2.00p
14:55 8,000 @ 2.01p
12:16 32,000 @ 2.10p

Top of Page